Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GLUCOPHAGE
- Metformin and Muscle Recovery
- Managing Chronic Tendon Pain by Metformin
- Efficacy of Injectable Vitamin D Supplementation in Females With Polycystic Ovary Syndrome
- Voxelotor CYP and Transporter Cocktail Interaction Study
- METFORMIN FOR ATRIAL FIBRILLATION
- A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors
- Bioequivalence Study of Metformin Hydrochloride 500 mg Film-Coated Tablets in Indonesia Healthy Subject
- Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
- GXR RM China BE Study (Darmstadt - Jiangsu)
- Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes
- Metformin Efficacy and Safety for Gastric Intestinal Metaplasia
- Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
- Molecular Effects of Aspirin & Metformin on Colonic Epithelium
- MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
- Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers
- Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Volunteers
- Fed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female Volunteers
- Fasting Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers
- MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women
- Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
- Effect of Metformin in Children With Type 1 Diabetes
- Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial
- Chiglitazar Added to Metformin for Type 2 Diabetes
- An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer
- GXR RM 500 mg Korea BE Study
- Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation
- Efficacy Assessment of Chinese Herbal Medicine Jiangtang Tiaozhi Recipe Treating Participants With Glucose and Lipid Metabolism Disturbances
- The Effect of Metformin on Breast Cancer Patients
- Effects of Metformin on Airway Ion Channel Dysfunction in Cystic Fibrosis-related Diabetes
- Metformin Versus Standard of Care Treatment in Pregnant Women With Prediabetes
- COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
- Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.
- Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.
- Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients
- Effect of Metformin on Visual Function in Patients With Glaucoma
- Effect of Metabolic Surgery on Live Birth Rate of Offspring in Obesity Polycystic Ovarian Syndrome Patients
- Metformin in Patients With Fragile X
- A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children With Multiple Sclerosis
- Metformin in Alzheimer's Dementia Prevention
- Bioequivalence Study for Acarbose/Metformin FDC
- Effects of Metformin on Low Back Pain
- Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.
- Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
- Comparison of Probiotics, Metformin & Their Combination Therapy in the Treatment of PCOS
- Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
- Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC Patients
- A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
- Metformin Effect on Fracture Healing in Post-Menopausal Women
- Metformin as RenoProtector of Progressive Kidney Disease
- Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
- Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer
- Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants
- Metformin in Children and Adults With Fragile X Syndrome
- Impact of Metformin on Immunity
- Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study
- Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients
- Metformin Use and Clinical Pregnancy Rate in Women With Unexplained Infertility
- Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics
- Effect and Safety of Benaglutide or Metformin in Patients With Simple Obesity Who Have Inadequate Weight Control
- Effects of Metformin During Nicotine Withdrawal
- Glucophage® Extended Release (XR) 750 Milligram (mg) Indonesia Bioequivalence (BE) Study
- Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong - Darmstadt)
- Gestational Diabetes and Pharmacotherapy (GAP)
- A Trial of Metformin in Individuals With Fragile X Syndrome
- Metformin Pharmacology in Human Cancers: A Proof of Principle Study
- USE THE SYSTEMIC METFORMIN IN MELASMA
- Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects
- Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions
- Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I
- Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.
- Glucophage Immediate Release (GIR) China Bioequivalence Study
- Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial
- Research of Exenatide for Overweight/Obese PCOS Patients With IGR
- Comparison of Metformin and Insulin for Management of Gestational Diabetes Mellitus
- A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes
- Diabetes Prevention With Lifestyle Intervention and Metformin Escalation
- Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects
- A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria
- Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome
- Role of Metformin on Muscle Health of Older Adults
- Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care In Kisarawe, Tanzania
- Phase II Lung Metcore - Preoperative Metformin for Lung Cancer
- Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
- Metformin in Intrahepatic Cholestasis of Pregnancy
- Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
- Metformin SR Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes
- Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome
- Fetal Hemoglobin Induction Treatment Metformin
- Metformin Therapy in HCV Infection
- Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
- Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
- Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss
- Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)
- Feasibility Study of Metformin Therapy in ADPKD
- Efficacity and Safety of Metformin XR in CKD Stage 1 to 3
- HbA1c Variability in Type II Diabetes
- Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
- The Effect of Metformin on Fecundability in an ART(Assisted Reproductive Technology) Setting - the Correlation to Uterine Flows
- Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study
- The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
- A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
- Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM
- Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome
- Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome
- The Effects of Metformin on Glycemic Control and Insulin Sensitivity in Adolescents With T1DM
- Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
- An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to
- Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2
- Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice
- A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers
- Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD
- Metformin Plus Sorafenib for Advanced HCC
- Metformin Immunotherapy in HIV Infection
- Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
- EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
- Effect of Metformin on Insulin Sensitivity and Pan-Arterial Vascular Function in Adults With Metabolic Syndrome
- Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes
- Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
- The Effect of Metformin on Different Hormones in PCOS Patients
- Milk Protein Feeding After Aerobic Exercise in Older Adults With Pre-diabetes Taking the Biguanide Metformin
- A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin
- Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
- The Effect of Gelesis100 on the Pharmacokinetics of Metformin
- Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients
- Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
- Testosterone, Metformin, or Both, for Hypogonadism in Obese Males
- Metformin And Longevity
- Phase 1 Bioavailability Study of SYR-322MET
- Heart Rate Variability in Response to Metformin Challenge
- Metformin And Chloroquine in IDH1/2-mutated Solid Tumors
- Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
- DiaFrail: A Short Duration Study in Older People ( DIAFRAIL Study)
- Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
- Metformin and Congenital Nephrogenic Diabetes Insipidus
- Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study
- Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM
- the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin
- Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity
- Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma
- Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer (METCAP).
- Metformin in Longevity Study (MILES).
- Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy
- Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study
- Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis
- Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg
- Metformin for Rising PSA Remote Trial
- Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer
- Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery
- Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Primary Prevention Hepatocellular Carcinoma by Metformin
- Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
- Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit
- Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants
- Bioequivalence Study of Metformin Component of Canagliflozin and Metformin Fixed Dose Combination Immediate Release (IR) Tablet Comparing With Metformin IR Tablet Co-administered With Canagliflozin Tablet in Healthy Fed and Fasted Participants
- Comparative Bioavailability Study of Metformin HCl 1000 mg Granules vs Glucophage 1000 mg Film-coated Tablet
- Metformin Treatment in Polycystic Ovary Syndrome (PCOS)
- Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR
- Bioequivalence Study of Two Strengths of Two Different Metformin Tablets Administered to Healthy Male and Female Subjects
- Metformin to Augment Low Milk Supply (MALMS) Study
- Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer
- Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy
- Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
- Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
- Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA
- Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)
- Common Variation at SLC16A11 and Other Genes on the Response to a Mixed Meal Tolerance Test
- The Hypotensive Effect of Metformin in Hypertensive Patients.
- Endogenous Opioid Activity and Affective State in Insulin Resistant Women
- Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
- Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes
- Endometrial Cancer Biomarker Changes Following Exposure to Metformin
- Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)
- Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
- Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
- Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis
- Metformin in the Diastolic Dysfunction of Metabolic Syndrome
- Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
- A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)
- Metformin in Stage IV Lung Adenocarcinoma
- Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate
- Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and Metformin
- Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer
- Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism.
- Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery
- Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes
- Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes
- Safety of Continuing Metformin in Diabetic Patients With Normal Kidney Function Receiving Contrast Media
- Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes
- Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes
- Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM
- Metformin Treatment in Gestational Diabetes and Noninsulin Dependent Diabetes in Pregnancy in a Developing Country
- Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML
- Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single Tablets
- Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition
- Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition
- Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes
- Metformin and Muscle in Insulin-resistant Older Veterans
- Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer
- Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
- Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients
- RISE Pediatric Medication Study
- RISE Adult Medication Study
- The Health Influences of Puberty (HIP) Study
- Metformin and Longevity Genes in Prediabetes
- A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
- Bioequivalence Study for Acarbose / Metformin FDC
- Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers
- Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia
- A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes
- ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia
- Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer
- BE Study of Metformin GSK 500mg
- Metformin for the Treatment of Endometrial Hyperplasia
- Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans
- Effect of Genetic Variation in the Transporter OCT2, MATE1 and MATE2-K on the PKPD of Metformin
- Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM
- Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer
- Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin
- Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance
- Study of Erlotinib and Metformin in Triple Negative Breast Cancer
- Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth
- Metabolic Abnormalities in HIV-infected Persons
- Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
- Efficacy of Metformin and Diane-35 on PCOS Patients,a Randomized, Controlled, Prospective Clinical Trial
- Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers
- Study of Metformin With Simvastatin for Men With Prostate Carcinoma
- Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg
- To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately
- Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM
- A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis
- Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets
- Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
- Metformin in Obese Children and Adolescents
- Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
- REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
- A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
- A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)
- Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)
- Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus
- Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers
- The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial
- Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
- Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
- Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
- Drug-Drug Interaction Study With Metformin and Nizatidine
- Drug-drug Interaction Study With Metformin and Imatinib
- Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet
- A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin
- Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)
- Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment
- Metformin and Sitagliptin in Women With Previous Gestational Diabetes
- Adjunctive Metformin Therapy in Double Diabetes
- Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI
- Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes
- Metformin in Obese Non-diabetic Pregnant Women
- Clinical Trial to Compare the Pharmacokinetics and Pharmacodynamics After Oral Administration of Glucophage and HL-018
- Reducing Antipsychotic-Induced Weight Gain in Children With Metformin
- Metformin to Reduce Heart Failure After Myocardial Infarction
- Metformin Combined With Chemotherapy for Pancreatic Cancer
- Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR
- Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer
- Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed Condition
- Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting Condition
- Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
- Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment
- Renal and Hormonal Effects of Pioglitazone
- Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions.
- Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fasting Conditions.
- Bioequivalence Study of Metformin Hydrochloride Extended Release 500 mg Tablet Versus Glucophage XR® 500 mg Tablet in Healthy Volunteers Under Fed Conditions
- Study to Compare the Bioavailability of Extended Release Metformin HCl Tablet Versus Glucophage XR® Tablets in Healthy Human Volunteers Under Fasting Condition
- Lapatinib With Sirolimus or Metformin
- To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
- Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered
- Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects
- Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants
- A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets
- Myocardial Perfusion in Type 2 Diabetes
- A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)
- Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes
- Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State
- Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics
- Safety and Tolerability of Trospium Chloride and Metformin Hydrochloride in Healthy Subjects
- Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers
- Metformin Compared to Glyburide in Gestational Diabetes
- A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)
- The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics
- Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subje
- Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult Su
- Triglyceride Lowering Study
- Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A)
- Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B)
- Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
- A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting Conditions
- A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting Conditions
- Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus
- Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes
- Metformin ER 750 mg Tablets, Fasting
- Metformin ER 750 mg Tablets, Fed
- A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)
- Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM
- The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
- Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
- Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
- Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions
- Bioequivalence Study of Gabapentin 400 mg Capsules Under Fed Conditions
- Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients
- Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions
- Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions
- Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions
- Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
- Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study
- Pharmacogenetics of Metformin Action in PCOS
- Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)
- Metformin for the Prevention of the Metabolic Side-effects of Zyprexa
- Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients
- Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes
- Assessment of Mechanisms of Improved Wound Healing
- Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome
- Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes
- Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients
- The Copenhagen Insulin and Metformin Therapy Trial
- Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)
- Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg
- Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg
- Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg
- Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg
- Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mg
- Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg
- Metformin in Amnestic Mild Cognitive Impairment
- EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance
- Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth
- Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes
- Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial
- Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
- Beta-Cell Function and Sitagliptin Trial (BEST)
- The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women
- Lifestyle Modification and Metformin Use in the Treatment of HIV
- Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
- Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus
- Impact of Genetics on Metformin Pharmacokinetics
- Genetic Basis for Variation in the Renal Elimination of Metformin
- Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects
- Insulin Resistance and Testosterone in Women
- Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)
- Diabetes Prevention Program Outcomes Study
- Ginkgo Biloba Extract and the Insulin Resistance Syndrome
Clinical trials list
click for details